FDA OKs glucose monitoring tool from Abbott

03/8/2012 | Endocrine Today

The FDA has approved Abbott's FreeStyle InsuLinx Blood Glucose Monitoring System, which aims to improve the way patients manage their diabetes. The technology includes an automated logbook to help users monitor blood glucose levels and insulin doses, among other features.

View Full Article in:

Endocrine Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC